209 related articles for article (PubMed ID: 23631440)
1. Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.
Jin Y; Roycik MD; Bosco DB; Cao Q; Constantino MH; Schwartz MA; Sang QX
J Med Chem; 2013 Jun; 56(11):4357-73. PubMed ID: 23631440
[TBL] [Abstract][Full Text] [Related]
2. The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.
Park HI; Jin Y; Hurst DR; Monroe CA; Lee S; Schwartz MA; Sang QX
J Biol Chem; 2003 Dec; 278(51):51646-53. PubMed ID: 14532275
[TBL] [Abstract][Full Text] [Related]
3. N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.
Nuti E; Cantelmo AR; Gallo C; Bruno A; Bassani B; Camodeca C; Tuccinardi T; Vera L; Orlandini E; Nencetti S; Stura EA; Martinelli A; Dive V; Albini A; Rossello A
J Med Chem; 2015 Sep; 58(18):7224-40. PubMed ID: 26263024
[TBL] [Abstract][Full Text] [Related]
4. Advances in matrix metalloproteinase inhibitors based on pyrrolidine scaffold.
Cheng XC; Wang Q; Fang H; Xu WF
Curr Med Chem; 2008; 15(4):374-85. PubMed ID: 18288992
[TBL] [Abstract][Full Text] [Related]
5. Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors.
Nuti E; Cuffaro D; D'Andrea F; Rosalia L; Tepshi L; Fabbi M; Carbotti G; Ferrini S; Santamaria S; Camodeca C; Ciccone L; Orlandini E; Nencetti S; Stura EA; Dive V; Rossello A
ChemMedChem; 2016 Aug; 11(15):1626-37. PubMed ID: 27356908
[TBL] [Abstract][Full Text] [Related]
6. A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.
Hugenberg V; Breyholz HJ; Riemann B; Hermann S; Schober O; Schäfers M; Gangadharmath U; Mocharla V; Kolb H; Walsh J; Zhang W; Kopka K; Wagner S
J Med Chem; 2012 May; 55(10):4714-27. PubMed ID: 22540974
[TBL] [Abstract][Full Text] [Related]
7. Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.
Beutel B; Daniliuc CG; Riemann B; Schäfers M; Haufe G
Bioorg Med Chem; 2016 Feb; 24(4):902-9. PubMed ID: 26810711
[TBL] [Abstract][Full Text] [Related]
8. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
[TBL] [Abstract][Full Text] [Related]
9. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
[TBL] [Abstract][Full Text] [Related]
10. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P
Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448
[TBL] [Abstract][Full Text] [Related]
11. Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation.
Nuti E; Santamaria S; Casalini F; Yamamoto K; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Marini AM; Salerno S; Taliani S; Da Settimo F; Nagase H; Rossello A
Eur J Med Chem; 2013 Apr; 62():379-94. PubMed ID: 23376997
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Eur J Med Chem; 2008 Oct; 43(10):2130-9. PubMed ID: 18362041
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.
Scozzafava A; Supuran CT
J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel benzofuroxan-based pyrrolidine hydroxamates as matrix metalloproteinase inhibitors with nitric oxide releasing activity.
Zhang H; Wang X; Mao J; Huang Y; Xu W; Duan Y; Zhang J
Bioorg Med Chem; 2018 Aug; 26(15):4363-4374. PubMed ID: 30093347
[TBL] [Abstract][Full Text] [Related]
15. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
Li W; Saji S; Sato F; Noda M; Toi M
Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
[TBL] [Abstract][Full Text] [Related]
16. New matrix metalloproteinase inhibitors based on γ-fluorinated α-aminocarboxylic and α-aminohydroxamic acids.
Behrends M; Wagner S; Kopka K; Schober O; Schäfers M; Kumbhar S; Waller M; Haufe G
Bioorg Med Chem; 2015 Jul; 23(13):3809-18. PubMed ID: 25921268
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
Jian M; Sun X; Cheng G; Zhang H; Li X; Song F; Liu Z; Wang Z
J Nat Prod; 2022 Oct; 85(10):2424-2432. PubMed ID: 36122348
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.
Nuti E; Casalini F; Santamaria S; Gabelloni P; Bendinelli S; Da Pozzo E; Costa B; Marinelli L; La Pietra V; Novellino E; Margarida Bernardo M; Fridman R; Da Settimo F; Martini C; Rossello A
Eur J Med Chem; 2011 Jul; 46(7):2617-29. PubMed ID: 21514700
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates.
Cuffaro D; Camodeca C; D'Andrea F; Piragine E; Testai L; Calderone V; Orlandini E; Nuti E; Rossello A
Bioorg Med Chem; 2018 Dec; 26(22):5804-5815. PubMed ID: 30429099
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating arylsulfonylureido and 5-dibenzo-suberenyl/suberyl moieties.
Ilies M; Banciu MD; Scozzafava A; Ilies MA; Caproiu MT; Supuran CT
Bioorg Med Chem; 2003 May; 11(10):2227-39. PubMed ID: 12713832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]